These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 24448199)

  • 1. Deletion of soluble epoxide hydrolase attenuates cardiac hypertrophy via down-regulation of cardiac fibroblasts-derived fibroblast growth factor-2.
    Zhang H; Wang T; Zhang K; Liu Y; Huang F; Zhu X; Liu Y; Wang MH; Tang W; Wang J; Huang H
    Crit Care Med; 2014 May; 42(5):e345-54. PubMed ID: 24448199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of endogenous adrenomedullin on cardiac hypertrophy, fibrosis, and renal damage.
    Niu P; Shindo T; Iwata H; Iimuro S; Takeda N; Zhang Y; Ebihara A; Suematsu Y; Kangawa K; Hirata Y; Nagai R
    Circulation; 2004 Apr; 109(14):1789-94. PubMed ID: 14967720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of peroxisome proliferator-activated receptor-γ downregulates soluble epoxide hydrolase in cardiomyocytes.
    Pang W; Li N; Ai D; Niu XL; Guan YF; Zhu Y
    Clin Exp Pharmacol Physiol; 2011 Jun; 38(6):358-64. PubMed ID: 21291492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble epoxide hydrolase inhibition does not prevent cardiac remodeling and dysfunction after aortic constriction in rats and mice.
    Morgan LA; Olzinski AR; Upson JJ; Zhao S; Wang T; Eisennagel SH; Hoang B; Tunstead JR; Marino JP; Willette RN; Jucker BM; Behm DJ
    J Cardiovasc Pharmacol; 2013 Apr; 61(4):291-301. PubMed ID: 23232840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposite effects of gene deficiency and pharmacological inhibition of soluble epoxide hydrolase on cardiac fibrosis.
    Li L; Li N; Pang W; Zhang X; Hammock BD; Ai D; Zhu Y
    PLoS One; 2014; 9(4):e94092. PubMed ID: 24718617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apocynin Attenuates Cardiac Injury in Type 4 Cardiorenal Syndrome via Suppressing Cardiac Fibroblast Growth Factor-2 With Oxidative Stress Inhibition.
    Liu Y; Liu Y; Liu X; Chen J; Zhang K; Huang F; Wang JF; Tang W; Huang H
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26109504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linking an insect enzyme to hypertension: angiotensin II-epoxide hydrolase interactions.
    Ai D; Shyy JY; Zhu Y
    Kidney Int; 2010 Jan; 77(2):88-92. PubMed ID: 19847158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qiliqiangxin inhibits the development of cardiac hypertrophy, remodeling, and dysfunction during 4 weeks of pressure overload in mice.
    Zou Y; Lin L; Ye Y; Wei J; Zhou N; Liang Y; Gong H; Li L; Wu J; Li Y; Jia Z; Wu Y; Zhou J; Ge J
    J Cardiovasc Pharmacol; 2012 Mar; 59(3):268-80. PubMed ID: 22075750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteopontin modulates angiotensin II-induced fibrosis in the intact murine heart.
    Collins AR; Schnee J; Wang W; Kim S; Fishbein MC; Bruemmer D; Law RE; Nicholas S; Ross RS; Hsueh WA
    J Am Coll Cardiol; 2004 May; 43(9):1698-705. PubMed ID: 15120833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble epoxide hydrolase inhibitor, TUPS, attenuates isoproterenol/angiotensin II-induced cardiac hypertrophy through mammalian target of rapamycin-mediated autophagy inhibition.
    Zhang H; Zhang K; Liang J; Yan W; Wu F; Xu W; Wu Z; Chen Y; Pan R; Wu G
    J Pharm Pharmacol; 2019 Aug; 71(8):1291-1300. PubMed ID: 31215026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basigin Promotes Cardiac Fibrosis and Failure in Response to Chronic Pressure Overload in Mice.
    Suzuki K; Satoh K; Ikeda S; Sunamura S; Otsuki T; Satoh T; Kikuchi N; Omura J; Kurosawa R; Nogi M; Numano K; Sugimura K; Aoki T; Tatebe S; Miyata S; Mukherjee R; Spinale FG; Kadomatsu K; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):636-46. PubMed ID: 26916734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldehyde dehydrogenase 2 deficiency blunts compensatory cardiac hypertrophy through modulating Akt phosphorylation early after transverse aorta constriction in mice.
    Xia G; Fan F; Liu M; Wang S; Wu J; Shen C; Han S; Wang C; Jia J; Zou Y; Hu K; Ge J; Sun A
    Biochim Biophys Acta; 2016 Sep; 1862(9):1587-93. PubMed ID: 27239698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIMF (Hypoxia-Induced Mitogenic Factor)-IL (Interleukin)-6 Signaling Mediates Cardiomyocyte-Fibroblast Crosstalk to Promote Cardiac Hypertrophy and Fibrosis.
    Kumar S; Wang G; Zheng N; Cheng W; Ouyang K; Lin H; Liao Y; Liu J
    Hypertension; 2019 May; 73(5):1058-1070. PubMed ID: 30827145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy.
    Ai D; Pang W; Li N; Xu M; Jones PD; Yang J; Zhang Y; Chiamvimonvat N; Shyy JY; Hammock BD; Zhu Y
    Proc Natl Acad Sci U S A; 2009 Jan; 106(2):564-9. PubMed ID: 19126686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489.
    Wang K; Liu F; Zhou LY; Long B; Yuan SM; Wang Y; Liu CY; Sun T; Zhang XJ; Li PF
    Circ Res; 2014 Apr; 114(9):1377-88. PubMed ID: 24557880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia regulates basal and induced DNA synthesis and collagen type I production in human cardiac fibroblasts: effects of transforming growth factor-beta1, thyroid hormone, angiotensin II and basic fibroblast growth factor.
    Agocha A; Lee HW; Eghbali-Webb M
    J Mol Cell Cardiol; 1997 Aug; 29(8):2233-44. PubMed ID: 9281454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of aortic and cardiac AT1 receptor gene expression in transgenic (mRen-2) 27 rats.
    Nickenig G; Laufs U; Schnabel P; Knorr A; Paul M; Böhm MP
    Br J Pharmacol; 1997 May; 121(1):134-40. PubMed ID: 9146897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450 epoxygenase metabolite, 14,15-EET, protects against isoproterenol-induced cellular hypertrophy in H9c2 rat cell line.
    Tse MM; Aboutabl ME; Althurwi HN; Elshenawy OH; Abdelhamid G; El-Kadi AO
    Vascul Pharmacol; 2013; 58(5-6):363-73. PubMed ID: 23466634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High density lipoprotein downregulates angiotensin II type 1 receptor and inhibits angiotensin II-induced cardiac hypertrophy.
    Lin L; Gong H; Ge J; Jiang G; Zhou N; Li L; Ye Y; Zhang G; Ge J; Zou Y
    Biochem Biophys Res Commun; 2011 Jan; 404(1):28-33. PubMed ID: 21094634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A distinct AMP-activated protein kinase phosphorylation site characterizes cardiac hypertrophy induced by L-thyroxine and angiotensin II.
    Jiang SY; Xu M; Ma XW; Xiao H; Zhang YY
    Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):919-25. PubMed ID: 20497424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.